nektar therapeutics (NKTR:NASDAQ GS)
Rubin Tuder M.D.
Member of Pulmonary Advisory Board,Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 55 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. Rubin Tuder, M.D, serves as a Scientific Advisor of The Alpha-1 Project, Inc. Dr. Tuder serves as a Member of Pulmonary Advisory Committee of Nektar Therapeutics. Dr. Tuder is a Director of Cardiopulmonary Pathology, Johns Hopkins University. Dr. Tuder is currently the Hart Family Professor of Medicine and director of the program in translational lung research at the University of Colorado Denver, School of Medicine. After completing a post-doctoral fellowship at ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Universidade de São Paulo
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|